ARCHIVES

ODAC To Advise FDA on First Biosimilars Application Jan. 7

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

Choice Of Reconstruction Can Depend On Who Consults

October 29, 2010

In Brief: Ireland Cancer Center Named Comprehensive; UPCI Appoints Four Program Directors

February 27, 1998

Tobacco Control: Cigarette Price Hikes Reduce Smoking, Study Confirms

August 7, 1998

UCLA, NYU, Ohio States Must Wait Longer For Comprehensive Status

November 28, 1975

DT Board Oks RFAs In Surgery, HIV, Breast Cancer

June 18, 1993

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

April 3, 1992